NFL Biosciences SA (ALNFL.PA)
EUR 1.88
(-2.59%)
EUR 1.88
(-2.59%)
| Breakdown | 2022 | 2021 | 2020 |
|---|---|---|---|
| Operating Cash Flow | 104.88 Thousand | 87 Thousand | 83.91 Thousand |
| Net Income | -2.44 Million | -978.24 Thousand | -261.5 Thousand |
| Depreciation & Amortization | 52.44 Thousand | 43.5 Thousand | 41.95 Thousand |
| Deferred income taxes | - | - | - |
| Stock-based compensation | - | - | - |
| Change in working capital | - | - | - |
| Other non-cash items | 2.49 Million | 1.02 Million | 303.45 Thousand |
| Investing Cash Flow | - | - | - |
| Investments in PPE | - | - | - |
| Acquisitions | - | - | - |
| Investment purchases | - | - | - |
| Sales/Maturities of investments | - | - | - |
| Other Investing Activities | - | - | - |
| Financing Cash Flow | - | - | - |
| Debt repayment | - | - | - |
| Dividends payments | - | - | - |
| Common Stock Repurchased | - | - | - |
| Common Stock Issuance | - | - | - |
| Other Financing Activities | - | - | - |
| Accounts receivables | - | - | - |
| Accounts payables | - | - | - |
| Inventory | - | - | - |
| Other working capital | - | - | - |
| Cash at beginning of period | 3.03 Million | 310.2 Thousand | 226.28 Thousand |
| Cash at end of period | 1.05 Million | 3.03 Million | 310.2 Thousand |
| Capital Expenditure | - | - | - |
| Effect of forex changes on cash | - | - | - |
| Net cash flow / Change in cash | -1.98 Million | 2.72 Million | 83.91 Thousand |
| Free Cash Flow | 104.88 Thousand | 87 Thousand | 83.91 Thousand |
| Breakdown | 2023 Q2 | 2022 FY | 2022 Q4 | 2021 FY | 2020 FY |
|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - |
| Net Income | -2.11 Million | -2.44 Million | -1.37 Million | -978.24 Thousand | -261.5 Thousand |
| Depreciation & Amortization | 28.75 Thousand | 52.44 Thousand | 26.7 Thousand | 43.5 Thousand | 41.95 Thousand |
| Deferred income taxes | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - |
| Change in working capital | - | - | - | - | - |
| Other non-cash items | 2.13 Million | 2.49 Million | 1.39 Million | 1.02 Million | 303.45 Thousand |
| Investing Cash Flow | - | - | - | - | - |
| Investments in PPE | - | - | - | - | - |
| Acquisitions | - | - | - | - | - |
| Investment purchases | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - |
| Financing Cash Flow | - | - | - | - | - |
| Debt repayment | - | - | - | - | - |
| Dividends payments | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - |
| Other Financing Activities | - | - | - | - | - |
| Accounts receivables | - | - | - | - | - |
| Accounts payables | - | - | - | - | - |
| Inventory | - | - | - | - | - |
| Other working capital | - | - | - | - | - |
| Cash at beginning of period | 1.05 Million | 3.03 Million | 2.04 Million | 310.2 Thousand | 226.28 Thousand |
| Cash at end of period | 3.35 Million | 1.05 Million | 1.05 Million | 3.03 Million | 310.2 Thousand |
| Capital Expenditure | - | - | - | - | - |
| Effect of forex changes on cash | - | - | - | - | - |
| Net cash flow / Change in cash | 2.3 Million | -1.98 Million | -990.68 Thousand | 2.72 Million | 83.91 Thousand |
| Free Cash Flow | 57.51 Thousand | 104.88 Thousand | 53.41 Thousand | 87 Thousand | 83.91 Thousand |
8147
IMMP
2139
6371
OMEX
QZMRF